Sale of 30,970 CNO (NYSE: CNO) shares via option exercise

Rhea-AI Filing Summary

A holder of CNO common stock filed a notice under Rule 144 to sell 30,970 shares through Morgan Stanley Smith Barney LLC on the NYSE. The aggregate market value of the planned sale is listed as $1,329,582.36.

The shares are shown as having been acquired on 02/12/2026 via a stock option exercise, paid in cash, in the same amount of 30,970 shares. The filing notes that 95,353,512 shares of this class were outstanding, providing a baseline for the size of the proposed sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	30970	1329582.36	95353512	02/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2026	Stock Option Exercise	ISSUER			30970	02/12/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CNO's Form 144 filing disclose?

The Form 144 shows a holder of CNO common stock plans to sell 30,970 shares. The proposed sale has an aggregate market value of $1,329,582.36 and will be executed through Morgan Stanley Smith Barney LLC on the NYSE.

How many CNO shares are proposed to be sold under this Form 144?

The filing lists a proposed sale of 30,970 CNO common shares. These shares were acquired on 02/12/2026 via a stock option exercise for the same amount, with the transaction paid in cash according to the disclosure.

What is the aggregate market value of the CNO shares in this Form 144?

The aggregate market value of the 30,970 CNO common shares to be sold is reported as $1,329,582.36. This value is based on the information provided for the proposed transaction and reflects the total market value of the planned sale.

How and when were the CNO shares in this Form 144 acquired?

The shares were acquired on 02/12/2026 through a stock option exercise from the issuer. The amount acquired was 30,970 common shares, matching the number proposed for sale, and the filing states the consideration was paid in cash.

Which broker will handle the CNO Form 144 share sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is listed as 1 New York Plaza, 8th Floor, New York, NY 10004, and the transaction is designated for the NYSE exchange.

How many CNO shares of this class are outstanding in the Form 144?

The document reports 95,353,512 shares of this class outstanding. This figure provides context for the relative size of the planned 30,970-share sale, indicating the sale represents only a small portion of the total outstanding shares.